Related Experiment Video
Updated: Feb 20, 2026

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
Variation in Psychotropic and Non-Psychotropic Prescribing in Nursing Homes: A Multi-Level EMR-Based Retrospective
Darly Dash1, Ahmad Rahim1,2, Henry Yu-Hin Siu3
1Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Background:
Antipsychotic medications remain widely used in nursing homes (NHs) despite guidelines discouraging potentially inappropriate use. While home-level variation is known, less is understood at the unit and organization levels, or across other psychotropic and non-psychotropic drugs. We examined prescribing variation across NHs in Ontario, Canada. We examined prescribing variation for psychotropic and non-psychotropic drugs across NH units, homes, and organizations in Ontario, Canada.
Methods:
We conducted a retrospective cohort study of NH residents using EMR data from April 1, 2022, to March 31, 2023. Outcomes included whether residents were prescribed any antipsychotic, antidepressant, statins, cardiovascular disease (CVD) medications, and trazodone for at least 1 day during the follow-up period. Multi-level logistic regression models adjusted for resident characteristics and included random intercepts for units, homes, and organizations.
Results:
Among 16,896 NH residents across 179 homes and five organizations, 39% were prescribed antipsychotics, 65.5% antidepressants, 33% statins, 65% CVD medications, and 38% trazodone. Substantial variation was observed across all medications. For antipsychotics, the home-level median odds ratio (MOR) was 1.65 (95% CrI: 1.52-1.78) and unit-level MOR was 1.24 (95% CrI: 1.10-1.33). Trazodone exhibited the highest variation (home-level MOR: 2.06, 95% CrI 1.75-2.37; unit-level MOR: 1.87, 95% CrI 1.76-1.97). No significant variation was found at the organization level. Resident characteristics, like aggression and dementia, were associated with prescribing but did not explain unit and home-level differences.
Conclusions:
Prescribing variation extends beyond antipsychotics to other common pharmacotherapies. Unit-level variation reveals additional unexplained variation not captured in previous home-level studies, providing new targets for research and quality improvement interventions. Future research should explore potential unit- and home-level contributors, such as staffing, practice culture, clinician decision-making, and policies.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Dosage Regimen: Individualization
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion